GlassScriptPhysician profile
Margaret R Edwards
NPI 1487940680
$1,275.31
in general payments reported to CMS, 2019-2025
14 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $186 · 2021: $50.80 · 2022: $38.01 · 2023: $269 · 2024: $241 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $412.41 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Pfizer INC. | $358.38 | 2019-2025 | |
| Allergan, INC. | $162.12 | 2020 | |
| Novartis Pharmaceuticals Corporation | $84.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $42.78 | 2019-2025 | Airsupra |
| Sunovion Pharmaceuticals INC. | $42.45 | 2019 | |
| Lilly USA, LLC | $40.11 | 2022-2024 | Zepbound, Mounjaro |
| Supernus Pharmaceuticals, INC. | $24.58 | 2019 | |
| Astellas Pharma US INC | $22.20 | 2019 | |
| Glaxosmithkline, LLC. | $20.80 | 2023 | Shingrix, Arexvy |
| Medtronic, INC. | $20.45 | 2025 | Inceptiv |
| Dexcom, INC. | $19.24 | 2024 | Dexcom G6 Transmitter |
| Amgen INC. | $13.71 | 2025 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.